Download PDF
Semin Neurol 2007; 27(5): 411-424
DOI: 10.1055/s-2007-991123
© Thieme Medical Publishers

Neurological Disorders in Pregnancy from a Neuroimaging Perspective

Steven D. Brass1 , William A. Copen2
  • 1Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts
  • 2Division of Neuroradiology, Massachusetts General Hospital, Boston, Massachusetts
Further Information

Publication History

Publication Date:
16 October 2007 (online)

    Permissions and Reprints

ABSTRACT

Pregnancy can precipitate new neurological diseases as a result of the alterations in physiology that accompany the pregnant state. The pregnant patient presenting with neurological problems poses both diagnostic and therapeutic challenges, often forcing the clinician to rely on neuroimaging as part of the workup. This review discusses potential risks to the embryo and fetus posed by computed tomography (CT) and magnetic resonance imaging (MRI), the imaging studies most often used to study the central nervous system. Imaging features of a variety of neurological conditions associated with pregnancy are discussed, including pre-eclampsia and eclampsia, Wernicke's encephalopathy, cerebral venous thrombosis, ischemic stroke, postpartum angiopathy, and lymphocytic hypophysitis.

KEYWORDS

Pregnancy - stroke - cortical venous thrombosis - eclampsia - choriocarcinoma - brain tumor

REFERENCES

  • 1 Wagner L K, Lester R G, Saldana L R. Exposure of the Pregnant Patient to Diagnostic Radiations: A Guide to Medical Management. Philadelphia; Lippincott 1985: 19-223
    Google Scholar
  • 2 Berlin L. Radiation exposure and the pregnant patient.  AJR Am J Roentgenol. 1996;  167 1377-1379
    PubMedGoogle Scholar
  • 3 Damilakis J, Prassopoulos P, Perisinakis K, Faflia C, Gourtsoyiannis N. CT of the sacroiliac joints: Dosimetry and optimal settings for a high-resolution technique.  Acta Radiol. 1997;  38 870-875
    PubMedGoogle Scholar
  • 4 Damilakis J, Perisinakis K, Voloudaki A, Gourtsoyiannis N. Estimation of fetal radiation dose from computed tomography scanning in late pregnancy: depth-dose data from routine examinations.  Invest Radiol. 2000;  35 527-533
    CrossrefPubMedGoogle Scholar
  • 5 Wagner L K, Archer B R, Zeck O F. Conceptus dose from two state-of-the-art CT scanners.  Radiology. 1986;  159 787-792
    PubMedGoogle Scholar
  • 6 Mole R H. Irradiation of the embryo and fetus.  Br J Radiol. 1987;  60 17-31
    CrossrefPubMedGoogle Scholar
  • 7 Giles D, Hewitt D, Stewart A, Webb J. Malignant disease in childhood and diagnostic irradiation in utero.  Lancet. 1956;  271 447
    PubMedGoogle Scholar
  • 8 Roberts P J, Given-Wilson R, Gifford D, Bryan G. Pregnancy and Work in Diagnostic Imaging. Report of a Joint Working Party of the Royal College of Radiologists and British Institute of Radiology. London; British Institute of Radiology 1992
    Google Scholar
  • 9 Mole R H. Childhood cancer after prenatal exposure to diagnostic x-ray examinations in Britain.  Br J Cancer. 1990;  62 152-168
    CrossrefPubMedGoogle Scholar
  • 10 United Nations Scientific Committee on the Effects of Atomic Radiation .Ionizing Radiation: Levels and Effects. 1972 Report to the General Assembly, with annexes. Vol. II: Effects. New York, NY; United Nations 1972
    Google Scholar
  • 11 Muirhead C R, Cox R, Stather J W et al.. Estimates of Late Radiation Risks to the UK Population. Documents of the NRPB 4[4]. Chilton; National Radiological Protection Board 1993: 15-157
    Google Scholar
  • 12 Ginsberg J S, Hirsh J, Rainbow A J, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease.  Thromb Haemost. 1989;  61 189-196
    PubMedGoogle Scholar
  • 13 Doll R, Wakeford R. Risk of childhood cancer from fetal irradiation.  Br J Radiol. 1997;  70 130-139
    CrossrefPubMedGoogle Scholar
  • 14 Gilman E A, Kneale G W, Knox E G, Stewart A M. Pregnancy x-rays and childhood cancers: effects of exposure age and radiation dose.  J Radiol Prot. 1988;  8 3-8
    CrossrefPubMedGoogle Scholar
  • 15 Benjamin S A, Lee A C, Angleton G M et al.. Neoplasms in young dogs after perinatal irradiation.  J Natl Cancer Inst. 1986;  77 563-571
    PubMedGoogle Scholar
  • 16 Idaho State University .Radiation and risk. Available at: http://www.physics.isu.edu/radinf/risk.htm Accessed December 10, 2006
    Google Scholar
  • 17 ACOG Committee on Obstetric Practice . ACOG Committee Opinion Number 299, September 2004. Guidelines for diagnostic imaging during pregnancy.  Obstet Gynecol. 2004;  104 647-651
    CrossrefPubMedGoogle Scholar
  • 18 Nelson J A, Livingston J C, Moon R G. Mutagenic evaluation of radiographic contrast media.  Invest Radiol. 1982;  17 183-185
    CrossrefPubMedGoogle Scholar
  • 19 Morisetti A, Tirone P, Luzzani F, de Haen C. Toxicologic safety assessment of iomeprol, a new x-ray contrast agent.  Eur J Radiol. 1994;  18(suppl 1) S21-S31
    CrossrefPubMedGoogle Scholar
  • 20 Ralston W H, Robbins M S, James P. Reproductive, developmental, and genetic toxicity of ioversol.  Invest Radiol. 1989;  24(suppl 1) S16-S22
    CrossrefPubMedGoogle Scholar
  • 21 Rodesch F, Camus M, Ermans A M, Dodion J, Delange F. Adverse effects of amniofetography on fetal thyroid function.  Am J Obstet Gynecol. 1976;  126 723-726
    PubMedGoogle Scholar
  • 22 Bona G, Zaffaroni M, Defilippi C, Gallina M R, Mostert M. Effects of iopamidol on neonatal thyroid function.  Eur J Radiol. 1992;  14 22-25
    CrossrefPubMedGoogle Scholar
  • 23 Webb J A, Thomsen H S, Morcos S K. Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) . The use of iodinated and gadolinium contrast media during pregnancy and lactation.  Eur Radiol. 2005;  15 1234-1240
    CrossrefPubMedGoogle Scholar
  • 24 Russell L B, Russell W L. An analysis of the changing radiation response of the developing mouse embryo.  J Cell Physiol. 1954;  43(suppl 1) 130-149
    PubMedGoogle Scholar
  • 25 Brent R L, Gorson R O. Radiation exposure in pregnancy. In: Moseley RD Jr., et al Current Problems in Radiology. Vol. 2. Chicago, IL; Year Book Medical Publishers Inc 1972: 1-48
    Google Scholar
  • 26 Blot W J, Miller R W. Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki.  Radiology. 1973;  106 617-619
    PubMedGoogle Scholar
  • 27 Yamazaki J N, Schull W J. Perinatal loss and neurological abnormalities among children of the atomic bomb: Nagasaki and Hiroshima revisited, 1949 to 1989.  JAMA. 1990;  264 605-609
    CrossrefPubMedGoogle Scholar
  • 28 Otake M, Schull W J. In utero exposure to A-bomb radiation and mental retardation: a reassessment.  Br J Radiol. 1984;  57 409-414
    CrossrefPubMedGoogle Scholar
  • 29 Dekaban A S. Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation to the human fetus.  J Nucl Med. 1968;  9 471-477
    PubMedGoogle Scholar
  • 30 Stewart A, Kneale G W. Radiation dose effects in relation to obstetric x-rays and childhood cancers.  Lancet. 1970;  1 1185-1188
    PubMedGoogle Scholar
  • 31 Wakeford R, Little M P. Risk coefficients for childhood cancer after intrauterine irradiation: a review.  Int J Radiat Biol. 2003;  79 293-309
    CrossrefPubMedGoogle Scholar
  • 32 Hall E J, Giaccia A J. Radiobiology for the Radiologist. Philadelphia; Lippincott Williams & Wilkins 2006
    Google Scholar
  • 33 Omnipaque [package insert]. Available at: http://www.amershamhealth-us.com/shared/pdfs/pi/Omnipaque.pdf Accessed December 18, 2006
    Google Scholar
  • 34 Heinrichs W L, Fong P, Flannery M et al.. Midgestational exposure of pregnant BALB/c mice to magnetic resonance imaging conditions.  Magn Reson Imaging. 1988;  6 305-313
    CrossrefPubMedGoogle Scholar
  • 35 Tyndall D A, Sulik K K. Effects of magnetic resonance imaging on eye development in the C57BL/6J mouse.  Teratology. 1991;  43 263-275
    CrossrefPubMedGoogle Scholar
  • 36 Yip Y P, Capriotti C, Talagala S L, Yip J W. Effects of MR exposure at 1.5T on early embryonic development of the chick.  J Magn Reson Imaging. 1994;  4 742-748
    CrossrefPubMedGoogle Scholar
  • 37 Kanal E, Shellock F G, Talagala L. Safety considerations in MR imaging.  Radiology. 1990;  176 593-606
    CrossrefPubMedGoogle Scholar
  • 38 National Radiological Protection Board .Principles for the Protection of Patients and Volunteers during Clinical Magnetic Resonance Diagnostic Procedures. Documents of the NRPB. Vol. 2, No. 1. London; HM Stationery Office 1991
    Google Scholar
  • 39 Shellock F G, Kanal E. Policies, guidelines, and recommendations for MR imaging safety and patient management.  J Magn Reson Imaging. 1991;  1 97-101
    PubMedGoogle Scholar
  • 40 Baker P N, Johnson I R, Harvey P R, Gowland P A, Mansfield P. A three-year follow-up of children imaged in utero with echo-planar magnetic resonance.  Am J Obstet Gynecol. 1994;  170 32-33
    CrossrefPubMedGoogle Scholar
  • 41 Glover P, Hykin J, Gowland P, Wright J, Johnson I, Mansfield P. An assessment of the intrauterine sound intensity level during obstetric echo-planar magnetic resonance imaging.  Br J Radiol. 1995;  68 1090-1094
    CrossrefPubMedGoogle Scholar
  • 42 Omniscan [package insert]. Available at: http://www.amershamhealth-us.com/shared/pdfs/pi/omniscan.pdf Accessed September 22, 2007
    Google Scholar
  • 43 Magnevist [package insert]. Available at: http://www.fda.gov/medwatch/SAFETY/2005/Jan_PI/Magnevist_PI.pdf Accessed December 18, 2006
    Google Scholar
  • 44 Kittner S J, Stern B J, Feeser B R et al.. Pregnancy and the risk of stroke.  N Engl J Med. 1996;  335 768-774
    CrossrefPubMedGoogle Scholar
  • 45 Wilterdink J L, Easton J D. Cerebral ischemia in pregnancy.  Adv Neurol. 2002;  90 51-62
    PubMedGoogle Scholar
  • 46 Wilterdink J L, Feldmann E. Intracranial hemorrhage.  Adv Neurol. 2002;  90 63-74
    PubMedGoogle Scholar
  • 47 Xavier A R, Qureshi A I, Kirmani J F, Yahia A M, Bakshi R. Neuroimaging of stroke: a review.  South Med J. 2003;  96 367-379
    CrossrefPubMedGoogle Scholar
  • 48 Grant P E, He J, Halpern E F et al.. Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain.  Radiology. 2001;  221 43-50
    PubMedGoogle Scholar
  • 49 Grossman RI, Yousem DM The Requisites: Neuroradiology. 2nd ed. Philadelphia; Elsevier 2003: 173-241
    Google Scholar
  • 50 Brant-Zawadzki M, Atkinson D, Detrick M, Bradley W G, Scidmore G. Fluid-attenuated inversion recovery (FLAIR) for assessment of cerebral infarction. Initial clinical experience in 50 patients.  Stroke. 1996;  27 1187-1191
    PubMedGoogle Scholar
  • 51 Lovblad K O, Laubach H J, Baird A E et al.. Clinical experience with diffusion-weighted MR in patients with acute stroke.  AJNR Am J Neuroradiol. 1998;  19 1061-1066
    PubMedGoogle Scholar
  • 52 Singer M B, Chong J, Lu D et al.. Diffusion-weighted MRI in acute subcortical infarction.  Stroke. 1998;  29 133-136
    PubMedGoogle Scholar
  • 53 van Everdingen K J, van der Grond J, Kappelle L J et al.. Diffusion-weighted magnetic resonance imaging in acute stroke.  Stroke. 1998;  29 1783-1790
    CrossrefPubMedGoogle Scholar
  • 54 Perkins C J, Kahya E, Roque C T, Roche P E, Newman G C. Fluid-attenuated inversion recovery and diffusion- and perfusion-weighted MRI abnormalities in 117 consecutive patients with stroke symptoms.  Stroke. 2001;  32 2774-2781
    CrossrefPubMedGoogle Scholar
  • 55 Gonzalez R G, Schaefer P W, Buonanno F S et al.. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset.  Radiology. 1999;  210 155-162
    PubMedGoogle Scholar
  • 56 Urbach H, Flacke S, Keller E et al.. Detectability and detection rate of acute cerebral hemisphere infarcts on CT and diffusion-weighted MRI.  Neuroradiology. 2000;  42 722-727
    CrossrefPubMedGoogle Scholar
  • 57 Fiebach J B, Schellinger P D, Jansen O et al.. CT and diffusion-weighted MR imaging in randomized order: diffusion-weighted imaging results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke.  Stroke. 2002;  33 2206-2210
    CrossrefPubMedGoogle Scholar
  • 58 Mullins M E, Schaefer P W, Sorensen A G et al.. CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department.  Radiology. 2002;  224 353-360
    CrossrefPubMedGoogle Scholar
  • 59 Manzione J, Newman G C, Shapiro A, Santo-Ocampo R. Diffusion- and perfusion- weighted MR imaging of dural sinus thrombosis.  AJNR Am J Neuroradiol. 2000;  21 68-73
    PubMedGoogle Scholar
  • 60 Ducreux D, Oppwnheim C, Vandamme X et al.. Diffusion-weighted imaging patterns of brain damage associated cerebral venous thrombosis.  AJNR Am J Neuroradiol. 2001;  22 261-268
    PubMedGoogle Scholar
  • 61 Mullins M E, Grant P E, Wang B, Gonzalez R G, Schaeffer P W. Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.  AJNR Am J Neuroradiol. 2004;  25 1666-1675
    PubMedGoogle Scholar
  • 62 Bateman B T, Schumacher H C, Bushnell C D et al.. Intracerebral hemorrhage in pregnancy: frequency, risk factors, and outcome.  Neurology. 2006;  67 424-429
    CrossrefPubMedGoogle Scholar
  • 63 Witlin A G, Friedman S A, Egerman R S, Frangieh A Y, Sibai B M. Cerebrovascular disorders complicating pregnancy: beyond eclampsia.  Am J Obstet Gynecol. 1997;  176 1139-1148
    CrossrefPubMedGoogle Scholar
  • 64 Moodley J, Kalane G. A review of the management of eclampsia: practical issues.  Hypertens Pregnancy. 2006;  25 47-62
    CrossrefPubMedGoogle Scholar
  • 65 Koch S, Rabinstein A, Falcone S, Forteza A. Diffusion-weighted imaging shows cytotoxic and vasogenic edema in eclampsia.  AJNR Am J Neuroradiol. 2001;  22 1068-1070
    PubMedGoogle Scholar
  • 66 Loureiro R, Leite C C, Kahhale S et al.. Diffusion imaging may predict reversible brain lesions in eclampsia and severe pre-eclampsia: initial experience.  Am J Obstet Gynecol. 2003;  189 1350-1355
    CrossrefPubMedGoogle Scholar
  • 67 Finocchi V, Bozzao A, Bonamini M et al.. Magnetic resonance imaging in posterior reversible encephalopathy syndrome: report of three cases and review of literature.  Arch Gynecol Obstet. 2005;  271 79-85
    CrossrefPubMedGoogle Scholar
  • 68 Shah A K, Whitty J E. Brain MRI in peripartum seizures: usefulness of combined T2 and diffusion weighted MR imaging.  J Neurol Sci. 1999;  166 122-125
    CrossrefPubMedGoogle Scholar
  • 69 Provenzale J M, Petrella J R, Cruz L CH, Wong J C, Engelter S, Barboriak D P. Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.  AJNR Am J Neuroradiol. 2001;  22 1455-1461
    PubMedGoogle Scholar
  • 70 Hinchey J, Chaves C, Appignani B et al.. A reversible posterior leukencephalopathy syndrome.  N Engl J Med. 1996;  334 494-500
    CrossrefPubMedGoogle Scholar
  • 71 Covarrubias D J, Luetmer P H, Campeau N G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.  AJNR Am J Neuroradiol. 2002;  23 1038-1048
    PubMedGoogle Scholar
  • 72 Schaefer P W, Buonanno F S, Gonzalez R G, Schwamm L H. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia.  Stroke. 1997;  28 1082-1085
    PubMedGoogle Scholar
  • 73 Ay H, Buonanno F S, Schaefer P W et al.. Posterior leukencephalopathy without severe hypertension: utility of diffusion-weighted MRI.  Neurology. 1998;  51 1369-1376
    CrossrefPubMedGoogle Scholar
  • 74 Geijer B, Sundgren P C, Lindgren A, Brockstedt S, Stahlberg F, Holtas S. The value of b required to avoid T2 shine-through from old lacunar infarcts in diffusion-weighted imaging.  Neuroradiology. 2001;  43 511-517
    CrossrefPubMedGoogle Scholar
  • 75 D'Aprile P, Farchi G, Pagliarulo R, Carella A. Thrombotic thrombocytopenic purpura: MR demonstration of reversible brain abnormalities.  AJNR Am J Neuroradiol. 1994;  15 19-20
    PubMedGoogle Scholar
  • 76 Singhal A B. Postpartum angiopathy with reversible posterior leukoencephalopathy.  Arch Neurol. 2004;  61 411-416
    CrossrefPubMedGoogle Scholar
  • 77 Neudecker S, Stock K, Krasnianski M. Call-Fleming postpartum angiopathy in the puerperium: a reversible cerebral vasoconstriction syndrome.  Obstet Gynecol. 2006;  107 446-449
    CrossrefPubMedGoogle Scholar
  • 78 Call G K, Fleming M C, Sealfon S, Levine H, Kistler J P, Fisher C M. Reversible cerebral segmental vasoconstriction.  Stroke. 1988;  19 1159-1170
    CrossrefPubMedGoogle Scholar
  • 79 Singhal A B, Caviness V S, Begleiter A F, Mark E J, Rordorf G, Koroshetz W J. Cerebral vasoconstriction and stroke after use of serotonergic drugs.  Neurology. 2002;  58 130-133
    CrossrefPubMedGoogle Scholar
  • 80 Ruggenenti P, Remuzzi G. The pathophysiology and management of thrombotic thrombocytopenic purpura.  Eur J Haematol. 1996;  56 191-207
    PubMedGoogle Scholar
  • 81 Bakshi R, Shaikh Z A, Bates V E, Kinkel P R. Thrombotic thrombocytopenic purpura: Brain CT and MRI findings in 12 patients.  Neurology. 1999;  52 1285-1288
    CrossrefPubMedGoogle Scholar
  • 82 Kanaan I, Jallu A, Kanaan H. Management strategy for meningioma in pregnancy: a clinical study.  Skull Base. 2003;  13 197-203
    Article in Thieme ConnectPubMedGoogle Scholar
  • 83 Mamelak A N, Withers G J, Wang X. Choriocarcinoma brain metastasis in a patient with viable intrauterine pregnancy.  J Neurosurg. 2002;  97 477-481
    Google Scholar
  • 84 Biousse V, Newman N J, Oyaizu N M. Precipitating factors in pituitary apoplexy.  J Neurol Neurosurg Psychiatry. 2001;  71 542-545
    CrossrefPubMedGoogle Scholar
  • 85 Masding M G, Lees P D, Gawne-Cain M L, Sandeman D D. Visual field compression by a non-secreting pituitary tumour during pregnancy.  J R Soc Med. 2003;  96 27-28
    CrossrefPubMedGoogle Scholar
  • 86 Kelestimur F. Sheehan's syndrome.  Pituitary. 2003;  6 181-188
    CrossrefPubMedGoogle Scholar
  • 87 Stelmach M, O'Day J. Rapid change in visual fields associated with suprasellar lymphocytic hypophysitis.  J Clin Neuroophthalmol. 1991;  11 19-24
    PubMedGoogle Scholar
  • 88 Flanagan D E, Ibrahim A E, Ellison D W, Armitage M, Gawne-Cain M, Lees P D. Inflammatory hypophysitis-the spectrum of disease.  Acta Neurochir (Wien). 2002;  144 47-56
    CrossrefPubMedGoogle Scholar
  • 89 McCutcheon I E, Oldfield E H. Lymphocytic adenohypophysitis presenting as infertility. Case report.  J Neurosurg. 1991;  74 821-826
    CrossrefPubMedGoogle Scholar
  • 90 Horvath E, Vidal S, Syro L V, Kovacs K, Smyth H S, Uribe H. Severe lymphocytic adenohypophysitis with selective disappearance of prolactin cells: a histologic, ultrastructural and immunoelectron microscopic study.  Acta Neuropathol (Berl). 2001;  101 631-637
    PubMedGoogle Scholar
  • 91 Miyagi K, Shingaki T, Ito K et al.. Lymphocytic infundibulo-hypophysitis with diabetes insipidus as a new clinical entity: a case report and review of the literature.  No Shinkei Geka. 1997;  25 169-175
    PubMedGoogle Scholar
  • 92 Ikeda H, Okudaira Y. Spontaneous regression of pituitary mass in temporal association with pregnancy.  Neuroradiology. 1987;  29 488-492
    CrossrefPubMedGoogle Scholar
  • 93 Osborn A. Diagnostic Neuroradiology. St. Louis; CV Mosby 1994
    Google Scholar
  • 94 Elster A D. Modern imaging of the pituitary.  Radiology. 1993;  187 1-14
    CrossrefPubMedGoogle Scholar
  • 95 Ikeda H, Yoshimoto T. Visual disturbances in patients with pituitary adenoma.  Acta Neurol Scand. 1995;  92 157-160
    CrossrefPubMedGoogle Scholar
  • 96 Saeki N, Uchino Y, Murai H et al.. MR imaging study of edema-like change along the optic tract in patients with pituitary region tumors.  AJNR Am J Neuroradiol. 2003;  24 336-342
    PubMedGoogle Scholar
  • 97 Arita K, Uozumi T, Yano T et al.. MRI visualization of complete bilateral optic nerve involvement by pituitary adenoma: a case report.  Neuroradiology. 1993;  35 549-550
    CrossrefPubMedGoogle Scholar
  • 98 Gallucci M, Bozzao A, Splendiani A, Masciocchi C, Passariello R. Wernicke encephalopathy: MR findings in five patients.  AJNR Am J Neuroradiol. 1990;  11 887-892
    PubMedGoogle Scholar
  • 99 Chung S P, Kim S W, Yoo I S et al.. Magnetic resonance imaging as a diagnostic adjunct to Wernicke encephalopathy in the ED.  Am J Emerg Med. 2003;  21 497-502
    CrossrefPubMedGoogle Scholar
  • 100 Togay-Isikay C, Yigit A, Mutluer N. Wernicke's encephalopathy due to hyperemesis gravidarum. Diffusion-weighted imaging abnormalities in Wernicke encephalopathy: reversible cytotoxic edema? An under-recognised condition.  Aust N Z J Obstet Gynaecol. 2001;  41 453-456
    CrossrefPubMedGoogle Scholar
  • 101 Chu K, Kang D W, Kim H J, Lee Y S, Park S H. Diffusion-weighted imaging abnormalities in Wernicke encephalopathy: reversible cytotoxic edema.  Arch Neurol. 2002;  59 123-127
    CrossrefPubMedGoogle Scholar
  • 102 Confavreux C, Hutchinson M, Hours M M et al.. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group.  N Engl J Med. 1998;  339 285-291
    CrossrefPubMedGoogle Scholar
  • 103 Soldan S S, Alavrez Retuerto A I, Sicotte N L, Voskuhl R R. Immune modulation in multiple sclerosis patients treated with pregnancy hormone estriol.  J Immunol. 2003;  171 6267-6274
    PubMedGoogle Scholar
  • 104 Sandhu F S, Dillon W P. Spinal epidural abscess: evaluation with contrast-enhanced MR imaging.  AJNR Am J Neuroradiol. 1991;  12 1087-1093
    PubMedGoogle Scholar
  • 105 Yonekawa Y, Mehdorn H M, Nishikaw M. Spontaneous spinal epidural hematoma during pregnancy.  Surg Neurol. 1975;  3 327-328
    PubMedGoogle Scholar
  • 106 Osei E K, Faulkner K. Fetal doses from radiological examinations.  Br J Radiol. 1999;  72 773-780
    PubMedGoogle Scholar

Steven David BrassM.D. M.P.H. F.R.C.P.C. 

Associate Director of Neurology Clinic, Assistant Professor of Neurology, Department of Neurology, Massachusetts General Hospital

55 Fruit Street, Wang Building, Suite 835, Boston, MA 02114

Email: sbrass@partners.org

      >